Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.75 USD
Change Today -0.21 / -0.96%
Volume 536.3K
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marsha H. Fanucci

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 4 different organizations across 5 different industries.

See Board Relationships
61$395,812

Background*

Ms. Marsha H. Fanucci served as Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals Inc., since July 2004 and also served as its Principal Accounting Officer. Ms. Fanucci served as Senior Vice President, Finance and Corporate Strategy of Millennium Pharmaceuticals Inc. from October 2003 to July 2004, Vice President of Finance and Corporate Strategy from July 2003 to October 2003 and Vice President, Corporate Development from July 2000 to July ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

2005-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2009-Present
Director and Chairman of Audit Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director and Chairman of Audit Committee

Education*

MBA
Northeastern University
BS
West Virginia University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$10,000
Total Calculated Compensation$395,812
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $21.75 USD -0.21

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$557.2K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
$440.2K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$650.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.